
Department of Medical Affairs & Pharmacovigilance • Clinical Formulary Monograph
D 92/6 Okhla Phase 1, New Delhi, 110020, India • Medical Helpline: +91 11-47532297 • Email: contact@vrmedhealthcare.com

Brogikoff
Bronchodilator, Mucolytic & Expectorant Cough Syrup
Brogikoff
Bronchodilator, Mucolytic & Expectorant Cough Syrup
Terbutaline Sulphate IP 1.25mg + Bromhexine Hydrochloride IP 4mg + Guaiphenesin IP 50mg per 5ml
Product Clinical Overview
Brogikoff is a sugar-free, orange-flavoured cough syrup combining Terbutaline, a selective beta-2 bronchodilator, with Bromhexine, a mucolytic, and Guaiphenesin, an expectorant. It relieves productive cough associated with bronchospasm by opening airways and helping to clear viscous mucus.
More Images
Actual Brogikoff packaging, label panels.
Key Ingredients & Pharmacological Profiles
Active chemical constituents, standardized strengths, and physiological roles.
Selective β2-agonist relaxing bronchial smooth muscle.
Mucolytic that depolymerises mucopolysaccharide fibres in sputum.
Expectorant increasing respiratory secretion volume to ease clearance.
Approved Clinical Indications
Clinical contexts where this formulation is prescribed under medical supervision.
Pharmacological Mechanism of Action
Terbutaline stimulates β2-adrenergic receptors, raising cAMP and relaxing airway smooth muscle. Bromhexine reduces sputum viscosity, and Guaiphenesin stimulates secretion of less viscous respiratory fluid, facilitating mucociliary clearance.
Formulation & Delivery Technology
- Sugar-free orange-flavoured syrup base
- Three-way action: bronchodilation, mucolysis and expectoration
- Age-banded paediatric and adult dosing
VR Med Healthcare Pvt. Ltd.
Registered Office & Facility:D 92/6 Okhla Phase 1, New Delhi, 110020, India
Quality Certifications:WHO-GMP Compliant & ISO 9001:2015 Certified
Medical Helpline:+91 11-47532297
Corporate Email:contact@vrmedhealthcare.com
Administration & Packaging Details
Adults & children over 12 years: 1 teaspoonful; 6–12 years: ½ teaspoonful; 1–6 years: ¼ teaspoonful — all doses 3 to 4 times a day or as directed by the Physician. Shake well before use.
100 ml Bottle
Store protected from light and moisture, at a temperature not exceeding 30°C. Keep the cap tightly closed after use.
This formulation monograph is published strictly for the professional scientific reference and educational use of Registered Medical Practitioners, Hospitals, and Clinical Laboratories. The technical and pharmacological details presented herein do not constitute medical advice, diagnostic opinion, or therapeutic claims. These products must be prescribed, dispensed, and administered strictly in accordance with local drug regulations and under the supervision of a licensed physician. VR Med Healthcare Pvt. Ltd. does not promote self-medication, off-label usage, or unsolicited consumer health claims.
More in Respiratory
Enhancing Lives With
Quality Healthcare & Integrity.
VR Med Healthcare has been a trusted benchmark in the Indian pharmaceutical sector since 2010. Headquartered in Okhla Phase 1, New Delhi, our dedicated team of over 100 professionals collaborates with leading physicians and distributors across India to make premium medicines accessible and reliable.
“Our goal is to deliver quality of care in a courteous, respectful, and compassionate manner. We hope you will allow us to care for you and strive to be the first and best choice for healthcare professionals and families.”
Kamal Choudhary
Managing Director, VR Med Healthcare
Established
Approved Formulations
Healthcare Specialists
Manufacturing Standard
